MA31601B1 - Dosage pour l'hydrocarbonate de lanthane - Google Patents

Dosage pour l'hydrocarbonate de lanthane

Info

Publication number
MA31601B1
MA31601B1 MA31414A MA31414A MA31601B1 MA 31601 B1 MA31601 B1 MA 31601B1 MA 31414 A MA31414 A MA 31414A MA 31414 A MA31414 A MA 31414A MA 31601 B1 MA31601 B1 MA 31601B1
Authority
MA
Morocco
Prior art keywords
assay
lanthane
hydrocarbonate
analysis
determining
Prior art date
Application number
MA31414A
Other languages
English (en)
Inventor
Donald Hallenbeck
Simon Bates
Original Assignee
Shire Int Licensing Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Int Licensing Bv filed Critical Shire Int Licensing Bv
Publication of MA31601B1 publication Critical patent/MA31601B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F17/00—Compounds of rare earth metals
    • C01F17/20—Compounds containing only rare earth metals as the metal element
    • C01F17/247—Carbonates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • G01N23/207—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Geology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

L'INVENTION CONCERNE UN DOSAGE PERMETTANT DE DÉTERMINER PAR ANALYSE LA TENEUR EN IMPURETÉS D'UN ÉCHANTILLON SOLIDE. CE PROCÉDÉ D'ANALYSE PAR DIFFRACTION DES RAYONS X COMPREND DE PRÉFÉRENCE UN RAFFINEMENT RIETVELD.
MA31414A 2006-05-05 2008-11-25 Dosage pour l'hydrocarbonate de lanthane MA31601B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/418,666 US20070259052A1 (en) 2006-05-05 2006-05-05 Assay for lanthanum hydroxycarbonate

Publications (1)

Publication Number Publication Date
MA31601B1 true MA31601B1 (fr) 2010-08-02

Family

ID=38661464

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31414A MA31601B1 (fr) 2006-05-05 2008-11-25 Dosage pour l'hydrocarbonate de lanthane

Country Status (15)

Country Link
US (3) US20070259052A1 (fr)
JP (1) JP2009536356A (fr)
KR (1) KR20090016465A (fr)
CN (1) CN101484798A (fr)
AU (1) AU2007248374A1 (fr)
BR (1) BRPI0710343A2 (fr)
CA (1) CA2651344A1 (fr)
EA (1) EA200802169A1 (fr)
IL (1) IL195051A0 (fr)
MA (1) MA31601B1 (fr)
MX (1) MX2008014148A (fr)
NO (1) NO20085063L (fr)
SG (1) SG171656A1 (fr)
TW (1) TW200742849A (fr)
WO (1) WO2007130721A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
CA2583548A1 (fr) * 2004-10-15 2006-04-27 Altairnano, Inc. Liant phosphate a prise de comprimes reduite
WO2010106557A2 (fr) * 2009-03-20 2010-09-23 Panacea Biotec Limited Formulations pharmaceutiques stables comprenant du carbonate de lanthane anhydre et procédé pour la préparation de celui-ci
EP2429950B1 (fr) * 2009-05-15 2013-04-17 Natco Pharma Limited Procédé pour la préparation de carbonate de lanthane dihydraté
US8961917B2 (en) * 2010-05-12 2015-02-24 Spectrum Pharmaceuticals, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
US8263119B2 (en) 2010-12-01 2012-09-11 Shire Llc Capsule formulations containing lanthanum compounds
US8697132B2 (en) 2010-12-01 2014-04-15 Shire Llc Capsule and powder formulations containing lanthanum compounds
CA2833645C (fr) * 2011-05-17 2019-09-17 Zach System S.P.A. Procede de detection de polymorphes a l'aide d'un rayonnement synchrotron
WO2013096776A2 (fr) * 2011-12-21 2013-06-27 Iso Therapeutics Group Llc Compositions radioactives et procédés pour leur utilisation thérapeutique
WO2013184373A1 (fr) 2012-06-05 2013-12-12 3M Innovative Properties Company Agents de concentration à base de lanthane destinés à des microorganismes
CN102671684B (zh) * 2012-06-06 2013-10-30 福州大学 一种复合光催化剂及其制备方法和应用
CN103604820A (zh) * 2013-11-27 2014-02-26 南京钢铁股份有限公司 一种提高xrd实验精度的方法
JP5968401B2 (ja) * 2014-11-12 2016-08-10 三菱重工業株式会社 高温部材の温度推定方法、準安定正方相の含有量測定方法、劣化判定方法
CN110579499A (zh) * 2018-06-08 2019-12-17 北京华睿鼎信科技有限公司 一种碳酸镧或其制剂中碱式碳酸镧杂质的检定方法
CN110095489A (zh) * 2019-05-22 2019-08-06 北京悦康科创医药科技股份有限公司 一种碳酸镧咀嚼片中杂质碱式碳酸镧的定量测定方法
CN111620363A (zh) * 2020-06-13 2020-09-04 南京卡文迪许生物工程技术有限公司 一种四水合碳酸镧的制备方法及其产品
CN113019305B (zh) * 2021-03-03 2021-10-15 重庆三峡学院 多孔碱式碳酸镧磷酸盐吸附剂的制备及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246246A (en) 1977-12-10 1981-01-20 Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry Method for manufacture of hydrated borates
US4592082A (en) * 1984-08-10 1986-05-27 The United States Of America As Represented By The United States Department Of Energy Quantitative determination of mineral composition by powder X-ray diffraction
JPH06705B2 (ja) 1985-12-19 1994-01-05 旭化成工業株式会社 リン酸イオンの固定化剤
US5045289A (en) 1989-10-04 1991-09-03 Research Corporation Technologies, Inc. Formation of rare earth carbonates using supercritical carbon dioxide
EP0620728B1 (fr) * 1992-01-13 1997-01-08 Pfizer Inc. Preparation de comprimes a efficacite amelioree
JPH06171950A (ja) 1992-12-02 1994-06-21 Shin Etsu Chem Co Ltd ランタンマンガナイト粉末の製造方法
US5562921A (en) * 1994-07-15 1996-10-08 Sherman; Bernard C. Stable solid pharmaceutical compositions containing enalapril maleate
US5435986A (en) * 1994-08-30 1995-07-25 Industrial Technology Research Institute Method for preparing high purity aluminum hydroxide
GB9506126D0 (en) * 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
US6281503B1 (en) * 1998-05-06 2001-08-28 Quanta Vision, Inc. Non-invasive composition analysis
US20010014352A1 (en) * 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
US6055293A (en) * 1998-06-30 2000-04-25 Seh America, Inc. Method for identifying desired features in a crystal
CN1122702C (zh) 1998-12-29 2003-10-01 中国石油化工集团公司 一种烃类催化裂化硫转移助剂及其使用方法
AUPQ109499A0 (en) 1999-06-21 1999-07-15 Adelaide Brighton Management Limited Sample presentation for x-ray diffraction
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
GB0015745D0 (en) 2000-06-27 2000-08-16 Shire Holdings Ag Treatment of bone diseases
EP1321142A1 (fr) 2001-12-21 2003-06-25 Novartis AG Forme solide pour l'administration orale du Tégaserode
US7469036B2 (en) * 2002-04-19 2008-12-23 Los Alamos National Security, Llc Analysis of macromolecules, ligands and macromolecule-ligand complexes
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US6678347B1 (en) 2002-07-26 2004-01-13 Hypernex, Inc. Method and apparatus for quantitative phase analysis of textured polycrystalline materials
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
US7256049B2 (en) 2003-09-04 2007-08-14 Tandem Labs Devices and methods for separating phospholipids from biological samples
DE10346433B4 (de) 2003-10-07 2006-05-11 Bruker Axs Gmbh Analytisches Verfahren zum Bestimmen von kristallographischen Phasen einer Messprobe
CA2574450C (fr) * 2004-07-27 2011-07-19 Shire Pharmaceuticals, Inc. Methode pour traiter l'hyperphosphatemie au moyen d'hydroxycarbonate de lanthane
CA2583548A1 (fr) 2004-10-15 2006-04-27 Altairnano, Inc. Liant phosphate a prise de comprimes reduite

Also Published As

Publication number Publication date
EA200802169A1 (ru) 2009-06-30
US20070259052A1 (en) 2007-11-08
TW200742849A (en) 2007-11-16
NO20085063L (no) 2008-12-04
US20080089948A1 (en) 2008-04-17
WO2007130721A2 (fr) 2007-11-15
WO2007130721A3 (fr) 2008-04-10
MX2008014148A (es) 2009-01-27
AU2007248374A2 (en) 2008-11-27
US7618656B2 (en) 2009-11-17
JP2009536356A (ja) 2009-10-08
SG171656A1 (en) 2011-06-29
AU2007248374A1 (en) 2007-11-15
CN101484798A (zh) 2009-07-15
IL195051A0 (en) 2009-08-03
BRPI0710343A2 (pt) 2011-08-09
KR20090016465A (ko) 2009-02-13
CA2651344A1 (fr) 2007-11-15
US20100092576A1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
MA31601B1 (fr) Dosage pour l'hydrocarbonate de lanthane
WO2010090471A3 (fr) Nouveau marqueur de diagnostic pour le diabète sucré de type 1
EP3130607A3 (fr) Anticorps du muc1*
ATE530915T1 (de) Freisetzungsreagens für vitamin-d-verbindungen
WO2008060394A3 (fr) Procédés et essais pour détecter des auto-anticorps spécifiques au gp73
EP2385053A3 (fr) Intermédiaires pour la préparation de composés bicycliques condensés comme inhibiteurs mTOR
MA34641B1 (fr) Anticorps anti-il-23
ZA200709956B (en) Pretreatment of a biological sample from an autoimmune disease subject
EP2106555A4 (fr) Procédé d'analyse d'échantillons au microscope électronique à transmission et/ou à balayage
IL184905A0 (en) Method for diagnosing multiple sclerosis
EP1962085A3 (fr) Appareil d'émission et de détection de faisceaux lumineux
UA95958C2 (en) Antibody that binds to cd22, immunoconjugates and uses therefor
FR2881436B1 (fr) Procede de determination de la diversite des lymphocytes t dans un echantillon biologique
EP2321430B8 (fr) Procédé d'évaluation du risque d'un cancer de la bouche chez un humain
WO2010019414A3 (fr) Détection d'acide nucléique
EP2194380A3 (fr) Détection d'un antigène- cible, indépendamment de la présence ou absence d'anticorps thérapeutiques correspondants
EP2154531A4 (fr) Procédé d'analyse d'un échantillon de métal
WO2008033575A3 (fr) Procédés d'identification de cheminements biochimiques
DE602005021026D1 (de) Vorrichtung zur absoluten Distanzmessung durch chromatische Fokussierung
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
SG179447A1 (en) The quantitative determination of risedronate in urine by spe-lc-ms-ms
EP1955076A4 (fr) Procede de determination de la qualite d un echantillon biologique
WO2006092729A3 (fr) Nouveaux biomarqueurs de diagnostic et/ou pronostic de neoplasies chez l'animal
EP2075341A4 (fr) Procédé d'étude, de détermination ou d'évaluation par l'analyse de l'expression d'un gène
MX2009005656A (es) Captura de microorganismos de tipo micobacteria.